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http:WHAT THIS PAPER ADDS
Patients with a ruptured AAA are often excluded from EVAR based on aortic morphology. This paper evaluates
technical and clinical outcomes of emergency EVAR in patients with hostile infrarenal aortic neck anatomy and
reports excellent results, suggesting that emergency EVAR in ruptured AAA with hostile aortic neck anatomy is
technically feasible and safe in experienced hands.Objective: To compare the mid-term results of endovascular aortic aneurysm repair (EVAR) for ruptured
abdominal aortic aneurysms (RAAAs) in patients with favourable aortic neck anatomy (FNA) and hostile aortic
neck anatomy (HNA).
Methods: Patients treated for a RAAA in a high volume endovascular centre in the Netherlands between
February 2009 and January 2014 were identiﬁed retrospectively and divided into two groups based on aortic
neck anatomy, FNA and HNA. HNA was deﬁned as RAAA with a proximal neck of <10 mm, or a proximal neck of
10e15 mm with a suprarenal angulation (a) >45 and/or an infrarenal angulation (b) >60, or a proximal neck of
>15 mm combined with a >60 and/or b >75. Patient demographics, procedure details, 30 day and 1 year
outcomes were recorded.
Results: Of 39 included patients, 17 (44%) had HNA. Technical success was 100% for FNA and 88% for HNA
(p ¼ .184). There were no type IA endoleaks on completion angiography in either group; however, more
adjunctive procedures were necessary for intra-operative type IA endoleaks in the HNA group (24% vs. 0%,
p ¼ .029). Thirty day mortality rates were comparable, FNA 14% vs. HNA 12% (p ¼ 1.000). There were no
statistically signiﬁcant differences at 1 year follow up in type I endoleaks, secondary endovascular procedures, or
all cause mortality.
Conclusion: Emergency EVAR provides excellent results for treatment of RAAA patients with both FNA and HNA.
EVAR in RAAAs with HNA is technically feasible and safe in experienced endovascular centres.
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A ruptured abdominal aortic aneurysm (RAAA) is fatal
without emergency surgical intervention. The ﬁrst report of
a successful endovascular treatment of RAAA was published
in 1994.1 With doctors becoming more experienced in
endovascular techniques, and also the improved availability
of off the shelf endografts, an increasing number of RAAA
patients undergo endovascular treatment. Endovascularrresponding author. Department of Vascular Surgery, Catharina
l, Michelangelolaan 2, P.O. Box 1350, 5602 ZA Eindhoven, The
lands.
il address: joep.teijink@catharinaziekenhuis.nl (J.A.W. Teijink).
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//dx.doi.org/10.1016/j.ejvs.2015.04.017aneurysm repair (EVAR) might improve short-term survival
rates of RAAA patients compared with traditional open
surgical repair (OR).2 The implementation of an EVAR ﬁrst
strategy for RAAAs in experienced centres shows an
improved clinical outcome.3 However, according to the best
available data, the IMPROVE trial, the AJAX trial, and a
recent meta-analysis, there is no signiﬁcant difference in
short-term survival rates between EVAR and OR.4e6
The choice between OR and EVAR is based on operator
preference, patient characteristics, and anatomical suit-
ability. Anatomical suitability is deﬁned in the instructions
for use (IFU) of each endograft. With the evolution of
endografts, the anatomical suitability for EVAR increased
from 20% to approximately 46e64% with current de-
vices.4,5,7 Unfavourable aneurysm anatomy and adverse
anatomical characteristics of the aortic neck could be
314 P.P.H.L. Broos et al.predictors of poorer short-term outcomes.8 However, in
experienced endovascular centres, an increasing number of
patients with abdominal aortic aneurysms (AAA) are treated
outside the IFU. In the authors’ experience, this certainly
includes RAAAs.
This study aimed to compare the 1 year results of EVAR
for RAAA patients with favourable aortic neck anatomy
(FNA) and hostile aortic neck anatomy (HNA).
METHODS
Patient selection
Patients with a proven RAAA were identiﬁed retrospectively
based on the Dutch administrative code for RAAA (406) in the
hospital records of a large, tertiary referral centre for car-
diovascular disease in the Netherlands. Patients were
included for this analysis if the RAAA had been treated by
means of EVAR between February 2009 and January 2014. A
RAAA was deﬁned as bleeding outside the adventitia of a
dilated aorticwall.The diagnosis of a ruptured AAAwas based
on clinical ﬁndings, an ultrasound (US) in the emergency
department, followed by a contrast enhanced computed
tomography angiography (CTA) to conﬁrm the diagnosis and
allow for precise treatment planning. Patients were excluded
if there was no evidence of a rupture. Patients who under-
went previous EVAR or OR were also excluded.
Patient clinical status, medical history, treatment and
follow up data were collected through hospital, emergency
department and operation records.Patient management
All patients were treated by (or under the supervision of) an
experienced endovascular surgeon. The type of treatment
(OR or EVAR) was left to the discretion of the surgeon,
although under an EVAR ﬁrst strategy. All patients scheduled
for endovascular treatment underwent pre-operative CTA to
determine baseline aortic and aneurysmal dimensions. Both
bifurcated and aorto-uni-iliac (AUI) devices were used,
including Endurant (Medtronic Vascular, Santa Rosa, CA, USA)
and Excluder (W.L. Gore and Associates, Flagstaff, AZ, USA).
All endografts were implanted through the common femoral
artery via a transverse surgical cutdown.
If the prognosis because of comorbidity was exceedingly
poor or if treatment options were limited, patients were
palliated.
Standard follow up of treated RAAA patients was per-
formed at 1 month with a CTA scan, and yearly thereafter
with CTA or duplex ultrasound.Anatomical evaluation
Two trained researchers blinded for treatment outcome,
reviewed all available pre-operative CTAs independently.
Measurements weremade using dedicated three dimensional
(3D) sizing software (3mensio, 3mensio Vascular, Bilthoven,
The Netherlands). The central lumen line (CLL) was generated
manually.Measurementswere takenperpendicular to theCLL,
and suprarenal and infrarenal angulations were determinedaccording to the method described by Van Keulen et al.9 In
case of a discrepancy of more than 2 mm neck length or 5
angulation, consensus was obtained by consultation with one
of the endovascular surgeons. A common iliac artery (CIA)with
a diameter 17 mm in males or 15 mm in females was
considered aneurysmal.10Deﬁnitions and outcomes
The study cohort of patients was divided into two groups
based on infrarenal aortic neck anatomy. FNA was deﬁned
as a proximal neck of 15 mm combined with a suprarenal
angulation (a) 60 and an infrarenal angulation (b) 75
or deﬁned as a proximal neck of 10 mm combined with a
45 and b 60. HNA was deﬁned as RAAAs with a
proximal neck of <10 mm, or a proximal neck of 10e15 mm
with a >45 and/or b >60, or a proximal neck of >15 mm
combined with a >60 and/or b >75. The limits corre-
spond with the instructions for use (IFU) for the Endurant
stent graft.
Technical success was deﬁned as successful delivery and
deployment of the endograft, without unintentional
coverage of renal or visceral arteries, followed by successful
removal of the delivery system, and the absence of either a
type I or III endoleak. Completion angiography was per-
formed to document any possible endoleaks and other
endograft related complications. The duration of procedure
was deﬁned as the time between arterial cutdown and
closure. Thirty day and 1 year outcomes included endograft
related complications, mortality rates, and need for sec-
ondary interventions. Signiﬁcant migration was deﬁned as a
displacement of the endograft of 10 mm. There was no
loss to follow up at 1 year.Statistical analysis
Statistical analyses were performed using SPSS version 21
for MAC (IBM Corporation, Armonk, NY, USA). Categorical
variables are presented as frequencies with percentages.
The c2 or Fisher’s exact test were used for categorical
variables depending on sample size. Continuous variables
are presented as mean  standard deviation (SD) or as
median and interquartile range (IQR) in case of skewed
data. Mean differences were assessed using independent
group t tests and median differences were assessed using
ManneWhitney U tests. A p value <.05 was considered
statistically signiﬁcant. A per protocol analysis was per-
formed for the technical endograft related observations. All
other variables were evaluated on an intention to treat
basis. Missing values were excluded for analysis. Follow up
data were analysed by KaplaneMeier life table analysis and
the log-rank test.
RESULTS
Patients
69 patients presented with a RAAA at the emergency
department between February 2009 and January 2014. Six
patients were rejected for surgery based on extensive
Table 2. Baseline aneurysm characteristics by neck anatomy.
Variable FNA
(N ¼ 22)a
HNA
(N ¼ 17)a
p-value
Suprarenal angulation
(a), degrees
27  17 47  19 .002c
Infrarenal angulation
(b), degrees
50  15 73  16 <.001c
Neck length, mm 35  14 22  16 .016c
Neck diameter, mm 23  4 22  4 .595c
Maximum AAAb
diameter, mm
70  17 86  15 .004c
Right iliac diameter, mm 22  18 16  5 .184c
Left iliac diameter, mm 19  9 17  8 .639c
Right femoral diameter, mm 10  4 9  2 .144c
Left femoral diameter, mm 10  2 9  2 .356c
Iliac aneurysm 55% (12/22) 35% (6/17) .232d
a Values are reported as mean  standard deviation or as fre-
quencies (%) (n/N).
b Abdominal aortic aneurysm.
c t test.
d Pearson chi-square.
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cardiopulmonary resuscitation. Of the 59 patients that un-
derwent an intervention, 12 patients (20%) underwent OR.
The primary reason for OR was the presence of a juxtarenal
aneurysm. The remaining 47 patients (80%) underwent
EVAR; eight of these patients were excluded because they
had a secondary rupture after previous AAA repair (5 OR
and 3 EVAR). The remaining 39 patients were included in
the present study. The FNA group consisted of 22 patients
(56%), and the remaining 17 patients (44%) were assigned
to the HNA group.
Pre-operative clinical and anatomic features
Demographic data, haemodynamic status, serum creatinine,
haemoglobin, and baseline risk factors of the study groups
are outlined in Table 1. There were no signiﬁcant differ-
ences in age, gender, haemodynamic stability, and risk
factors. Mean pre-operative AAA measurements are listed
in Table 2. The HNA group tended to have a larger
maximum AAA diameter (HNA 86  15 mm vs. FNA
70  18 mm, p ¼ .004). The shortest proximal neck was
4 mm, and the largest a and b were 85 and 90, respec-
tively. In the HNA group, seven (41%) patients had a prox-
imal aortic neck length <10 mm, seven (41%) patients had
a suprarenal angulation >60, and 11 (65%) patients had an
infrarenal angulation >75.
Intra-operative results
Operation time was signiﬁcantly longer for HNA (HNA 122
[IQR 88-179] min vs. FNA 87 [IQR 65-104] min p ¼ .021).
There was trend for implanting more AUI devices in HNATable 1. Patient demographics and risk factors by neck anatomy.
Variables FNA (N ¼ 22)a HNA (N ¼ 17)a p
Age, years 72.6  8.2 75.6  6.5 .230b
Female 18% (4/22) 18% (3/17) 1.000c
Admission data
Pulse (beats per min) 85  21 79  13 .378b
Blood pressure (mmHg)
Systolic 112  29 114  37 .920b
Diastolic 69  19 67  21 .843b
Haemoglobin (mmol/L) 7.3  1.2 7.0  1.4 .589b
Creatinine (mmol/L) 115 (82e130) 110 (98e138) .573d
Risk factors
Tobacco use 22% (4/18) 35% (6/17) .471c
Hypertension 79% (15/19) 71% (12/17) .706c
Hypercholesterolaemia 67% (12/18) 59% (10/17) .631e
Diabetes 11% (2/18) 6% (1/17) 1.000c
Cancer 17% (3/18) 6% (1/17) .603c
Cardiac disease 39% (7/18) 41% (7/17) .890e
Pulmonary disease 17% (3/18) 29% (5/17) .443c
Renal insufﬁciency 6% (1/18) 6% (1/17) 1.000c
Denominator differs when there are missing values.
a Values are reported as mean  standard deviation, median and
interquartile range (IQR), or as frequencies (%) (n/N).
b t test.
c Fisher’s Exact test.
d Kruskal-Wallis test.
e Pearson chi-square.patients; however, the difference was not signiﬁcant
(Table 3). One HNA patient had no endograft implanted
because of iliac access difﬁculties. Severe comorbidities
meant that this patient was not converted to open surgery
and died within 24 hours. Intra-operative type IA endoleaks
were more frequent in the HNA group (Table 3). However,
all endoleaks were addressed and resolved during the initial
procedure. All intra-operative endoleaks required the use of
a balloon expandable stent, and in one patient an extension
cuff was added. Unintentional overstenting of both renal
arteries occurred in one HNA patient. A hepato-renal bypass
was performed to preserve blood ﬂow to one kidney.
Technical success was 100% (22/22) for FNA and 88% (15/
17) for HNA (p ¼ .184). Two FNA patients (9%) and two HNA
patients (12%) died within 24 hours of surgery.
Thirty day outcome
Within 30 days of implant, three FNA patients (13%) died,
versus two HNA patients (12%, p ¼ 1.000), including the
direct post-operative deaths. One month imaging was per-
formed in 33 implanted patients (85%), one patient was
diagnosed with metastasised cancer therefore no follow up
was planned. Table 4 presents the 30 day clinical and
technical outcomes. One FNA patient developed a type IA
endoleak on post-operative day one, which required open
surgical correction. Unfortunately, the patient died during
this procedure. One HNA patient was converted to open
repair because of an AAA re-rupture based on a type IA
endoleak on post-operative day three. One type IB endoleak
was reported in an HNA patient, requiring an extension cuff
just to the level of the hypogastric artery. An endograft limb
occlusion was observed in an FNA patient, which was cor-
rected by converting the bifurcated graft to an AUI graft in
combination with a femoro-femoral bypass. A total of four
HNA patients (24%) versus zero FNA patients developed an
abdominal compartment syndrome, which required
decompression laparotomy (p ¼ .029).
Table 3. Initial procedural data and evaluation by neck anatomy.
Variable FNA (N ¼ 22)a HNA (N ¼ 17)a p
Duration of procedure (min) 87 (65e104) 122 (88e179) .021c
Anaesthesia used .584d
General 50% (11/22) 59% (10/17)
Local or regional 50% (11/22) 41% (7/17)
Conﬁguration endograft .147e
Bifurcated 95% (21/22) 76% (13/17)
AUIb 5% (1/22) 24% (4/17)
Device name 1.000e
Endurant 95% (21/22) 100% (17/17)
Excluder 5% (1/22) 0% (0/17)
Adjunctive procedures
Resolve endoleak type IA 0% (0/22) 24% (4/17) .029e
Resolve endoleak type III 0% (0/22) 6% (1/17) .436e
Completion angiography
Endoleak type IA 0% (0/22) 0% (0/17) e
Endoleak type III 0% (0/22) 0% (0/17) e
Unintentional overstenting of renal artery 0% (0/22) 6% (1/17) .436e
Basic outcome
Technical success 100% (22/22) 88% (15/17) .184e
No implant 0% (0/22) 6% (1/17) .436e
Conversion to open surgery 0% (0/22) 0% (0/17) e
Dead within 24 hours 9% (2/22) 12% (2/17) 1.000e
a Values are reported as median and interquartile range (IQR) or as frequencies (%) (n/N).
b Aorto-uni-iliac.
c KruskaleWallis test.
d Pearson chi-square.
e Fisher’s Exact test.
Table 4. Patient outcome within 30 days by neck anatomy.
Variable FNA
(N ¼ 22)a
HNA
(N ¼ 17)a
pe
Technical outcomeb
Endoleak type IA 5% (1/19) 7% (1/14) 1.000
Endoleak type IB 0% (0/19) 7% (1/14) .424
Endoleak type III 0% (0/19) 0% (0/14) e
Endograft occlusion 5% (1/19) 0% (0/14) 1.000
Endograft migration 0% (0/19) 0% (0/14) e
Clinical outcomec
Secondary surgical
procedures
Endovascular procedure 5% (1/22) 6% (1/17) 1.000
Laparotomy for ACSd 0% (0/22) 24% (4/17) .029
Conversion to open
surgery
5% (1/22) 6% (1/17) 1.000
Aneurysm rupture 0% (0/22) 6% (1/17) .421
All cause mortality 14% (3/22) 12% (2/17) 1.000
a Values are reported as frequencies (%) (n/N).
b Per protocol analysis. Only patients with 30 day imaging were
included in the analysis.
c Intention to treat analysis. All patients were included in the
analysis.
d Abdominal compartment syndrome.
e Fisher’s Exact test.
Table 5. Patient outcome at 1 year by neck anatomy.
Variable FNA (N ¼ 22)a HNA (N ¼ 17)a pc
Endograft related complicationsb
Endoleak type IA 0% (0/16) 0% (0/12) e
Endoleak type IB 0% (0/16) 0% (0/12) e
Endoleak type III 6% (1/16) 0% (0/12) 1.000
Endograft occlusion 0% (0/16) 0% (0/12) e
Endograft migration 0% (0/16) 0% (0/12) e
a Values are reported as frequencies (%) (n/N).
b Per protocol analysis. Only patients with 1 year imaging were
included in the analysis.
c Fisher’s Exact test.
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One year imaging was available for 28 (72%) patients
(Table 5). No new type I endoleaks were reported in either
group. One FNA patient developed a type III endoleak,which was corrected endovascularly with an interposition
graft. Freedom from device related secondary interventions
at 1 year was comparable between groups (FNA 85% vs.
HNA 87%, p ¼ .962, Fig. 1). In addition, there were no
signiﬁcant differences in estimated freedom from all cause
mortality (FNA 77% vs. HNA 65%, p ¼ .413, Fig. 2). Within 1
year, four HNA patients died (urosepsis, sepsis of unknown
origin, cardiac, incarcerated femoral hernia). In the FNA
group two patients died (metastasised cancer, pulmonary
insufﬁciency). In all patients there were no stent graft
related complications.DISCUSSION
To the authors’ knowledge, this is the ﬁrst report that
evaluates the outcomes of EVAR in RAAAs with hostile
aortic neck anatomy. Encouraging results are reported with
Figure 1. KaplaneMeier curves representing the 1 year freedom
from device related secondary interventions (log-rank, p ¼ .962).
Five patients in the FNA group and six patients in the HNA group
died within 1 year and were censored.
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FNA and HNA patients.
Mortality is of the utmost importance in the discussion of
whether patients with hostile anatomical features should
be treated with EVAR. In this study, following an EVAR ﬁrst
strategy, the overall 30 day or in hospital mortality was 13%.
This is in line with reports showing an improvement in 30
day mortality in various centres that changed from an OR
ﬁrst to an EVAR ﬁrst approach.11 When taking aneurysmFigure 2. KaplaneMeier curves representing the 1 year freedom
from all cause mortality (log-rank, p ¼ .413).morphology into account, it has been shown that especially
short infrarenal neck length inﬂuences mortality, as it does
in OR.12 In OR this is most likely caused by the need for high
cross clamping, impairing circulation of the visceral arteries.
In this study the mortality rates were not inﬂuenced by the
suitability for EVAR (FNA 14% vs. HNA 12% p ¼ 1.000). This
supports the authors’ view that patients should not be
denied endovascular surgery based on hostile anatomical
features alone, especially when considering that data on
emergency EVAR in HNA are limited and OR in this popu-
lation shows no survival beneﬁt.12
In this study, 44% of patients undergoing EVAR had HNA.
This is in contrast with reports estimating that 17e30% of
elective patients are treated outside IFU.13,14 Anatomical
unsuitability for EVAR remains one of the main reasons to
treat AAAs via open surgery, and there have been reports
stating that up to 80% of RAAAs are regarded as not suit-
able for EVAR.7 However, unsuitability is based on pre-
clinically obtained test data and deﬁned by the
manufacturer. With increasing experience, off label use of
several stent grafts has become widely accepted in elective
surgery.
The discrepancy between the present results and those
from previous reports on suitability can be explained partly
in that juxtarenal AAAs underwent OR and were not
included in this analysis. However, this does not account for
the difference between elective and emergency EVAR. One
reason for the high number of patients treated with HNA
may be the diameter of the AAA. In this study, the mean
AAA diameter was signiﬁcantly larger for HNA patients.
Besides increasing the risk of a rupture, a large AAA diam-
eter may also negatively inﬂuence infrarenal neck length or
shape, or both, which can result in a higher percentage of
RAAAs regarded as unsuitable for EVAR.7 Although the
present study shows no difference between HNA and FNA
at 1 year, the larger AAA diameter could contribute to a
higher re-intervention rate at long-term follow up as has
been previously described.15
The present results did show a signiﬁcantly higher rate of
adjunctive procedures for intra-operative type IA endoleaks
in HNA patients. Comparable results can be found in studies
reporting the outcome of EVAR in elective AAA patients
with hostile infrarenal necks. A recent meta-analysis of
these studies also concluded that patients with hostile neck
anatomy required signiﬁcantly more adjunctive procedures
to resolve intra-operative type IA endoleaks (FNA 9% vs.
HNA 22%, p <.001).16 Remarkably, however, the present
study reported a comparable rate of adjunctive procedures
of 24% in HNA patients, even though there was notably less
time for procedure planning compared with elective sur-
gery. This indicates that emergency planning by an experi-
enced vascular surgeon was adequate, and did not lead to
an increased need for adjunctive procedures.
Although EVAR requires lifelong follow up and has an
increased secondary intervention rate compared with OR,
no differences were found in the need for secondary in-
terventions between HNA and FNA within 1 year. This
ﬁnding is in line with previous reports on AAAs with
318 P.P.H.L. Broos et al.challenging aortic necks treated with comparable devices in
an elective setting.17e19 This implies that the need for
secondary interventions within 1 year of follow up was not
inﬂuenced by the emergency setting and the higher number
of adjunctive procedures in the present study.
A marked advantage of EVAR is that its physiological
impact is notably reduced compared with OR, because of
the possibility of local anaesthesia and the avoidance of
aortic cross clamping. A recent study by Gupta et al. sup-
ports this theory, with an improved mortality in unstable
patients who received EVAR.20 On the other hand, the AJAX
trial and IMPROVE trial did not show any signiﬁcant dif-
ferences in 30 day mortality between EVAR and OR.4,5
However, it should be noted that these two randomised
trials reported only on a selected group of patients with
RAAA and are not necessarily generalisable to the general
population. Moreover, the nature of these trials did not
permit surgeons to perform the procedure they personally
prefer.
Although the present study suggests that a hostile
infrarenal neck is not necessarily a reason for OR, there are
limitations to the use of a “regular” endograft, depending
on the extent of neck hostility. Several techniques have
been developed to increase EVAR suitability, one of which is
the chimney technique introduced by Greenberg et al.21
This is a cheap and readily available procedure and there-
fore ideal for RAAAs. However, evidence is scarce and
consists of small studies, and case reports without long-
term follow up.22
Even without advanced techniques, a low percentage
(14%) of RAAA patients were rejected for intervention. This
ﬁnding may inform the debate on rejection for repair, which
is considered to be subject to many inﬂuencing factors. In
the current literature, rejection rates vary greatly between
centres and countries, ranging from 20% to up to 42%.23
These differences arise because of the wide variation in
criteria used to decide whether or not to operate on a
patient. Some patients are rejected for any form of surgery
because anatomy does not allow EVAR and comorbidity
precludes OR.
At the authors’ hospital, treatment decisions are based
on a multitude of anatomical and patient characteristics.
Therefore, the present patient sample ranges from small
haemodynamically stable retroperitoneal haemorrhaging
to large free intraperitoneal ruptures. While open surgery
is probably lethal in the latter patients, they may poten-
tially survive EVAR in combination with optimised in
hospital logistics (availability of pre-operative CT scan, an
experienced endovascular team, and immediate availabil-
ity of a variety of endografts) and the use of permissive
hypotension.3
In clinical practice, a CT scan is essential, even in an
emergency setting, to determine the best surgical care and
to make a substantiated decision to perform open or
endovascular surgery. A previous study suggests that, in the
majority of RAAA patients, there is enough time to obtain
CT imaging, assess AAA morphology and EVAR suitability,
and transfer the patient to the operating theatre.24This study is limited by the small sample size and the
single centre design. Because of the low rate of complica-
tions, modern stent grafts require a large patient sample in
which to detect signiﬁcant differences. The results of
emergency EVAR were described in a hospital with three
vascular surgeons performing over 100 EVARs annually and
these results may not be generalisable to centres with less
experience in EVAR. Further prospective studies, with a
larger group of patients, and longer follow up are necessary
to evaluate the safety and durability of EVAR in patients
with RAAAs and hostile infrarenal aortic neck anatomy.CONCLUSION
EVAR in RAAAs with hostile infrarenal aortic necks appears
technically feasible and safe in experienced hands. Endog-
raft related complication rates and secondary intervention
rates were not signiﬁcantly higher in RAAA patients with
HNA at 1 year.CONFLICT OF INTEREST
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